Literature DB >> 30830549

Assessment of treatment efficacy using surface-enhanced Raman spectroscopy analysis of urine in rats with kidney transplantation or kidney disease.

Shijian Feng1,2, Lan Zhou1,3, Duo Lin4, Jianhua Zhao5, Qiunong Guan1, Boyuan Zheng1, Kunjie Wang2, Hong Li2, Rong Chen6, Haishan Zeng7, Caigan Du8.   

Abstract

BACKGROUND: Individuals who have kidney disease or kidney transplants need routine assessment of their kidney damage and function, which are largely measured based on histological examination of kidney biopsies, blood test, and urinalysis. These methods are practically difficult or inconvenient, and expensive. The objective of this study was to develop a model to estimate the kidney damage and function by surface-enhanced Raman spectroscopy (SERS).
METHODS: Urine samples were collected from two previous studies: renal allograft recipient Lewis rats receiving anti-TGF-β antibody or control antibody treatment and obese diabetic ZSF1 rats with kidney disease fed with whole grape powder-containing chow or control chow. Silver nanoparticle-based SERS spectra of urine were measured. SERS spectra were analyzed using principal component analysis (PCA) combined with linear discriminant analysis (LDA) and partial least squires (PLS) analysis.
RESULTS: PCA/LDA separated anti-TGF-β antibody-treated group from control group with 90% sensitivity and 70% specificity in kidney transplants, and grape-fed group from controls with 72.7% sensitivity and 60% specificity in diabetic kidneys. The receiver operating characteristic curves showed that the integration area under the curve was 0.850 ± 0.095 (p = 0.008) in kidney transplant groups and 0.800 ± 0.097 (p = 0.02) in diabetic kidney groups. PLS predicted the biochemical parameters of kidney function using the SERS spectra, resulting in R2 = 0.8246 (p < 0.001,urine protein), R2 = 0.8438 (p < 0.001, urine creatinine), R2 = 0.9265 (p < 0.001, urea), R2 = 0.8719 (p < 0.001, serum creatinine), and R2 = 0.6014 (p < 0.001, urine protein to creatinine ratio).
CONCLUSION: Urine SERS spectral analysis suggesting that it may become a convenient method for rapid assessment of renal impairment.

Entities:  

Keywords:  Diagnosis; Kidney disease; Kidney transplantation; Surface-enhanced Raman spectroscopy; Urine

Year:  2019        PMID: 30830549     DOI: 10.1007/s10157-019-01721-w

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  3 in total

1.  Analyzing the serum of hemodialysis patients with end-stage chronic kidney disease by means of the combination of SERS and machine learning.

Authors:  Lyudmila A Bratchenko; Sahar Z Al-Sammarraie; Elena N Tupikova; Daria Y Konovalova; Peter A Lebedev; Valery P Zakharov; Ivan A Bratchenko
Journal:  Biomed Opt Express       Date:  2022-08-24       Impact factor: 3.562

2.  Comparison of Surface-Enhanced Raman Scattering Properties of Serum and Urine for the Detection of Chronic Kidney Disease in Patients.

Authors:  Ming Zong; Lan Zhou; Qiunong Guan; Duo Lin; Jianhua Zhao; Hualin Qi; David Harriman; Lieying Fan; Haishan Zeng; Caigan Du
Journal:  Appl Spectrosc       Date:  2020-10-29       Impact factor: 2.388

Review 3.  The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases.

Authors:  Patrycja Paluszkiewicz; Adrian Martuszewski; Natalia Zaręba; Kamila Wala; Mirosław Banasik; Marta Kepinska
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.